Dynavax Technologies Corporation (DVAX) has a consensus analyst rating of Buy, based on 11 analysts covering the stock. Of those, 9 recommend buying, 1 recommend holding, and 1 recommend selling.
The analyst consensus price target for DVAX is $31.00, representing a +100.0% upside from the current price of $15.5. Price targets range from a low of $31.00 to a high of $31.00.
